Orcl stock pe ratio
WebApr 13, 2024 · The firm has a market capitalization of $253.51 billion, a PE ratio of 30.99, a price-to-earnings-growth ratio of 2.92 and a beta of 1.00. The firm’s 50-day moving average is $88.75 and its two ... WebOracle (NYSE:ORCL) Forward PE Ratio : 15.63 (As of Today) View and export this data going back to 1986. Start your Free Trial Oracle's Forward PE Ratio for today is 15.63. Oracle's PE Ratio without NRI for today is 28.97. Oracle's PE Ratio for today is 28.97. Oracle Forward PE Ratio Historical Data
Orcl stock pe ratio
Did you know?
WebMar 27, 2024 · About PE Ratio (TTM) Oracle Corporation has a trailing-twelve-months P/E of 17.60X compared to the Computer - Software industry's P/E of 27.76X. Price to Earnings … WebP/E ratio for Oracle (ORCL) P/E ratio as of April 2024 (TTM): 30.6 According to Oracle 's latest financial reports and stock price the company's current price-to-earnings ratio …
WebApr 12, 2024 · ORCL Stock Overview Oracle Corporation offers products and services that address enterprise information technology environments worldwide. About the company Rewards Trading at 32.3% below our estimate of its fair value Earnings are forecast to grow 17.55% per year Earnings have grown 7.8% per year over the past 5 years WebApr 6, 2024 · It has a P.E ratio of 30.93. The shares of Oracle Corp. are trading at $95.92 . Corporate Announcements Oracle Corp. Dividends September,2024 In the quarter ending September,2024. Oracle Corp. has declared dividend of $0.4 Read More Oracle Corp. Earnings Oracle Corp.’s price-to-earnings ratio stands at 31.32 Read More Discover more
WebCurrent and historical daily PE Ratio for Oracle Corp ( ) from 1990 to Mar 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most … WebOracle EPS for the quarter ending February 28, 2024 was $0.68, a 19.05% decline year-over-year. Oracle EPS for the twelve months ending February 28, 2024 was $3.04, a 17.37% increase year-over-year. Oracle 2024 annual EPS was $2.41, a 47.03% decline from 2024. Oracle 2024 annual EPS was $4.55, a 47.73% increase from 2024.
WebApr 14, 2024 · The company has a market capitalization of $257.97 billion, a PE ratio of 31.53, a price-to-earnings-growth ratio of 2.92 and a beta of 1.00. Oracle has a 52 week low of $60.78 and a 52 week high ...
WebApr 13, 2024 · The stock is rated as a Hold by 16 analyst(s), 13 recommend it as a Buy and 1 called the ORCL stock Overweight. In the meantime, 2 analyst(s) believe the stock as Underweight and 1 think it is a Sell. ... The PE ratio stands at 30.86 for Oracle Corporation, compared to 31.52 for Microsoft Corporation, and 22.20 for Alphabet Inc. Other than that ... bio heragold cWebApr 5, 2024 · The p/e ratio for Oracle (ORCL) stock today is 31.21.It's worsened by 4.38% from its 12-month average of 29.90. ORCL's forward pe ratio is 16.39. The p/e ratio is calculated by taking the latest closing price and dividing it … bio henry cavillWebFind out all the key statistics for Oracle Corporation (ORCL), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History ... biohep technologies ltdWebApr 5, 2024 · About PEG Ratio (TTM) Currently, Oracle Corporation has a PEG ratio of 2.35 compared to the Computer - Software industry's PEG ratio of 2.16. The company's trailing … bio hemp life minsanWebYou can buy and sell Oracle (ORCL) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. ... Price-Earnings ratio. 30.88. Price-Earnings ratio 30.88. Dividend yield. 1.36%. Dividend yield 1.36%. Average volume. 7.63M. ... Sign up for a Robinhood brokerage account to buy or sell ... daily gemini astroyogiWebApr 10, 2024 · Oracle Corporation (ORCL) NYSE - Nasdaq Real Time Price. Currency in USD. Follow. 2W 10W 9M. 93.72 -0.04 (-0.04%) As of 11:46AM EDT. Market open. Dividend. daily gemini horoscope sfgateWebApr 5, 2024 · The p/e ratio for Oracle (ORCL) stock today is 31.21. It's worsened by 4.38% from its 12-month average of 29.90. ORCL's forward pe ratio is 16.39. The p/e ratio is … biohep tablet